PALIPERIDONE
Manufacturer: Major Pharmaceuticals
Score: 144.0
Paliperidone is an atypical antipsychotic used for the treatment of schizophrenia and schizoaffective disorder. It is available in extended-release tablets and has a dose range of 3-12 mg/day for adults and 1.5-12 mg/day for adolescents. The drug has warnings for increased mortality in elderly patients with dementia-related psychosis, cerebrovascular adverse reactions, neuroleptic malignant syndrome, QT prolongation, and tardive dyskinesia. Contraindications include known hypersensitivity to paliperidone or risperidone. Adverse reactions include extrapyramidal symptoms, somnolence, and increased prolactin levels.
Increased mortality in elderly patients with dementia-related psychosis
Dose adjustments may be necessary for patients with renal impairment or hepatic impairment
6 mg/day
3 mg/day for adolescents weighing < 51 kg, 3-6 mg/day for adolescents weighing ≥ 51 kg
6 mg/day
Not established